Understanding Basic Stock Data: Abbott Laboratories (ABT)

In the past 52-week period, shares of Abbott Laboratories (NYSE:ABT) have moved within the range of $37.38 to $56.69. On the stock’s most recent trading day, the company’s shares ended the regular session at $55.80, which is 1.57% lower than its 52-week high.

Abbott Laboratories (ABT) has demonstrated a 20-day simple moving average (SMA) of 1.27%, and a 50-day SMA of 2.72%. This public company’s current market capitalization stands at $97.09 billion.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for Abbott Laboratories (ABT) is Outperform.

When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Abbott Laboratories (ABT) delivered a 1.67% surprise with its net revenue. Sales reached $6.83 billion during the three-month period, compared to the average analyst estimate of $6.72 billion.

Meanwhile, during the same quarter Abbott Laboratories (ABT) delivered a 1.18% earnings surprise. Net earnings for the quarter were posted at $0.66 per share, whereas Wall Street had forecast $0.65 per share.

Ownership at Abbott Laboratories (ABT), According to Most Recent SEC Filings

A public company’s latest 13F filings tell investors important details about institutional ownership. Abbott Laboratories (ABT) has 0 billion shares outstanding currently, 73.52% of which belong to institutional investors. Those institutional holdings amount to $71.41 billion.

Additionally, according to the most recent 13F filing from Abbott Laboratories (ABT), there were 87 new positions totaling 3,682,211 shares of the company’s stock. There were 62 sold out positions, on the other hand, totaling 16,352,796 shares.

Short, Medium and Long Term Indicators

Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. Abbott Laboratories (ABT) has had a 20-day average volume of 5,227,820 shares, with an average of 80% of short term indicators pointed at Buy.

The stock’s 50-day average volume has been 5,816,416 shares, with an average of 100% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 5,435,381 shares with 67% of long-term indicators pointing to Buy.